Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $19.48
- Average 1Y price target
- $25.72+32.03%
- Agreement
- Fair
Analysts agreement range is spread 15% to 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall3
- DCF3
- Return on equity5
- Return on assets5
- Debt / equity1
- P/E1
- P/B1
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 1 | $25.00 |
| Last quarter | 9 | $24.62 |
| Last year | 24 | $20.71 |
| All time | 30 | $19.09 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 28, 2026 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Oct 2, 2026 | Goldman Sachs | maintain | Neutral | Neutral |
| Oct 2, 2026 | Craig-Hallum | maintain | Buy | Buy |
| Sep 25, 2026 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Aug 26, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Aug 19, 2026 | Northland Capital Markets | maintain | Outperform | Outperform |
| Aug 4, 2026 | Goldman Sachs | maintain | Neutral | Neutral |
| Aug 3, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Jun 26, 2026 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Apr 29, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Apr 1, 2026 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Mar 26, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Feb 3, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Feb 2, 2026 | Goldman Sachs | maintain | Neutral | Neutral |
| Jan 26, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Dec 17, 2025 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Nov 25, 2025 | Goldman Sachs | maintain | Neutral | Neutral |
| Oct 6, 2025 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Oct 6, 2025 | Goldman Sachs | maintain | Neutral | Neutral |
| Aug 18, 2025 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Jul 22, 2025 | Oppenheimer | maintain | Outperform | Outperform |
| Jul 2, 2025 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Jun 27, 2025 | Goldman Sachs | upgrade | Sell | Neutral |
| Jun 12, 2025 | Goldman Sachs | maintain | Sell | Sell |
| Apr 14, 2025 | Goldman Sachs | maintain | Sell | Sell |
| Jan 14, 2025 | Keefe, Bruyette & Woods | maintain | Market Perform | Market Perform |
| Oct 22, 2024 | UBS | maintain | Buy | Buy |
| Jul 29, 2024 | Oppenheimer | maintain | Outperform | Outperform |
| Jul 29, 2024 | Northland Capital Markets | maintain | Outperform | Outperform |
| Jul 29, 2024 | Keefe, Bruyette & Woods | maintain | Market Perform | Market Perform |
| Jul 29, 2024 | Craig-Hallum | maintain | Buy | Buy |
| Jul 12, 2024 | Keefe, Bruyette & Woods | maintain | Market Perform | Market Perform |
| Apr 29, 2024 | Oppenheimer | maintain | Outperform | Outperform |
| Apr 22, 2024 | Oppenheimer | maintain | Outperform | Outperform |
| Apr 17, 2024 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Apr 12, 2024 | UBS | maintain | Buy | Buy |
| Apr 3, 2024 | Northland Capital Markets | upgrade | Market Perform | Outperform |
| Feb 5, 2024 | Oppenheimer | maintain | Outperform | Outperform |
| Jan 12, 2024 | Oppenheimer | maintain | Outperform | Outperform |
| Dec 28, 2023 | Northcoast Research | upgrade | Neutral | Buy |